OLMA
Olema Pharmaceuticals
$10.69
+$0.33 (+3.19%)Sep 10, 2026
Key metrics
The numbers that frame OLMA today
- Market cap
- $935.35M
- P/E (TTM)
- -4.6
- EV / FCF
- -5.4
- ROIC
- -53.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $6.65
- 52wk High
- $36.26
Growth
Revenue and earnings trend for OLMA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about OLMA
Is Olema Pharmaceuticals a good buy?
No. Olema Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Olema Pharmaceuticals is selling at a very high price.
What is the market capitalization of OLMA?
Olema Pharmaceuticals's market capitalization is $935.35M.
What is the P/E ratio for OLMA stock?
Olema Pharmaceuticals's current P/E ratio is -4.6.
What is the 52-week high for OLMA stock?
The 52-week high for Olema Pharmaceuticals is $36.26. The current close of $10.69 is 70.5% below that high.
What is the 52-week low for OLMA stock?
The 52-week low for Olema Pharmaceuticals is $6.65. The current close of $10.69 is 60.8% above that low.
Does OLMA stock pay dividends?
Olema Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for OLMA?
Olema Pharmaceuticals's Debt / Equity ratio is 0.01.